Indiana University School of Medicine student Gloria Xue has been selected by the Association of American Medical Colleges (AAMC) to serve on its board of directors for a two-year term beginning Nov. 5, 2025. Xue will be the only student on the board, representing the interests of medical students nationwide.
“The AAMC plays a large role in determining the future of medical education and academic medicine through their initiatives and responses,” Xue said. “I am incredibly honored to have the opportunity to represent the voices of students across the nation.”
The AAMC Board of Directors is led by incoming chair Michael Waldrum, MD, MSc, MBA, dean of the Brody School of Medicine at East Carolina University and CEO of ECU Health. IU Health President and CEO Dennis Murphy also serves on the AAMC board.
Xue currently serves as the national chair of the AAMC Organization of Student Representatives, the student branch of the AAMC which represents medical students enrolled in the 165 accredited U.S. medical schools.
At IU, she played an integral role in the School of Medicine’s recent reaccreditation process as vice chair of the Independent Student Analysis Committee (ISA).
“She authored the section on Learning Environment and Facilities in the ISA report and, based on student feedback, developed a three-pronged recommendation plan, which is now being implemented by the school,” Emily Walvoord, MD, interim senior associate dean for medical student education, wrote in a recommendation letter for Xue to the AAMC selection committee.
Walvoord noted Xue’s leadership with the IU School of Medicine Medical Student Council along with her undergraduate background in health care management and policy. As a medical student, Xue has participated in the Business of Medicine Scholarly Concentration program and completed a project studying the costs and financial impact of the IU School of Medicine Student Outreach Clinic in Indianapolis. Her findings are now being used to improve clinic efficiency and patient care.
“Gloria’s ability to envision new organizational solutions, evaluate tradeoffs in resources and outcomes, and implement improvements at an enterprise level makes her uniquely suited to represent student views while bearing in mind the AAMC’s financial health during these challenging times,” Walvoord wrote.
In addition to her medical studies, Xue is training in research through the Medical Scientist Training Program. As an MD/PhD, she aims to study and treat dermatologic cancers.
In her national role on the AAMC Board of Directors, Xue will attend monthly meetings as the board addresses issues including research funding, student loan pathways and Medicaid funding, which affects students’ ability to train at hospitals with diverse patient populations.
“I anticipate that these challenges, in addition to the current general distrust in medicine and science, will be major areas that the board will continue addressing during the coming academic year,” Xue said.
Read more about Xue’s interests and leadership experiences.
